Genelux GNLX
NASDAQ GNLX
$2.07 -0.43 (-17.20%)
At close: Oct 21, 2026 · 4:00 PM EDT

Genelux (GNLX) Total Debt (2022 - 2023)

Updated

Genelux (GNLX) reported Total Debt of $40,000 for Q4 2023, down 99.7% from $15.41 million a year earlier and unchanged from the prior quarter.

Analysis

Genelux (GNLX) Total Debt (2022 - 2023) Analysis & Trends

  • By year, Total Debt came in at $15.41 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 49.04 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 70.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 32.35 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 63.19 Bn
10 Genelux 91.17 Mn 29.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 40,000.00
Sep 30, 2023 40,000.00
Dec 31, 2022 16.51 Mn
API Access

Genelux Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=GNLX&period=max&api_key=YOUR_API_KEY